BA
The Boeing Company
BA has slightly lower modeled downside risk, despite its lower overall score.
NPO
EnPro Industries, Inc.
NPO has the edge over BA overall on the model score.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
NPO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
NPO's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over NPO in the historical PE scenario, which offers more potential upside but is not a forecast.
NPO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $28.27 | -90% |
| Forward | 25x | $279 | — |
| Fair | 48x | $141 | -49% |
| Current | 95x | $279 | — |
| Expensive | 143x | $420 | +51% |
Historical ranges are pointers, not guarantees.
NPO's PE is 95x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
NPO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NPO, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
NPO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.15 | +279% |
| Q3 2026 | $2.94 | -28% |
| Q2 2026 | $2.07 | -48% |
| Q1 2026 | $2.05 | -49% |
| Q4 2025 | $1.91 | -45% |
| Q3 2025 | $4.06 | +59% |
| Q2 2025 | $3.99 | +99% |
| Q1 2025 | $4.01 | +$4.16 |
| Q4 2024 | $3.45 | +229% |
NPO's earnings per share have fallen from their peak: $2.94 over the past year, against $11.80 in early 2020.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
NPO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.8M | +22% |
| Q2 2026 | $338.8M | +18% |
| Q1 2026 | $303M | +11% |
| Q4 2025 | $295.4M | +14% |
| Q3 2025 | $286.6M | +9.9% |
| Q2 2025 | $288.1M | +6% |
| Q1 2025 | $273.2M | +6.1% |
| Q4 2024 | $258.4M | +3.7% |
NPO's revenue has grown year over year for nine quarters in a row: $351M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +3.8 points |
| Q2 2026 | 17% | +1.2 points |
| Q1 2026 | 14% | -0.9 points |
| Q4 2025 | 11% | -1.2 points |
| Q3 2025 | 14% | +1.2 points |
| Q2 2025 | 16% | -1.8 points |
| Q1 2025 | 15% | +4.4 points |
| Q4 2024 | 12% | +4.2 points |
NPO has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
NPO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $69.8M | +31% |
| Q2 2026 | $35.7M | -16% |
| Q1 2026 | $27.4M | +111% |
| Q4 2025 | $50.5M | +2.9% |
| Q3 2025 | $53.4M | +11% |
| Q2 2025 | $42.3M | +10% |
| Q1 2025 | $13M | +$14.9M |
| Q4 2024 | $49.1M | +22% |
NPO generated $183M in free cash flow over the past year, up 16% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
NPO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.7x | Healthy |
NPO has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
NPO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.5 | Neutral |
| Stochastic | 13.8 | Oversold |
NPO's weekly RSI is 46 (neutral) and its Stochastic is 14 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over NPO on valuation relative to its sector.
NPO PE vs Industrials Sector
| Metric | NPO | Sector median | Relative |
|---|---|---|---|
| PE | 95x | 24x | 294% above |
| PE % | 78 | 58 | 20 pts above |
NPO is trading at 95x earnings, a 294% premium to the Industrials sector's median of 24x, though its earnings don't support one.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
NPO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $289.1 | 3.6% below |
| 20 week MA | $306.4 | 9.1% below |
| 50 week MA | $285.3 | 2.4% below |
| 100 week MA | $239.5 | 16% above |
| 200 week MA | $189.2 | 47% above |
NPO has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
NPO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66.4 | $74.9 | +13% |
| 2021 | $74.9 | $110.3 | +47% |
| 2022 | $110.3 | $111.0 | +0.6% |
| 2023 | $111.0 | $156.7 | +41% |
| 2024 | $156.7 | $173.5 | +11% |
| 2025 | $173.5 | $223.9 | +29% |
| 2026 YTD | $223.9 | $278.6 | +24% |
NPO has the edge over BA on returns for 2026, with the stronger performance.